Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Single-Arm Study to Assess the Efficacy of UVADEX® (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS® CELLEX® Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02524847
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:02.133517+00:00
Published At
2020-09-11T00:00:00+00:00
Record Updated At
2020-09-11
Results Posted At
2020-09-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Steroid Refractory Acute Graft Versus Host Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-11"
protocolSection.identificationModule.nctId
"NCT02524847"
protocolSection.identificationModule.officialTitle
"Single-Arm Study to Assess the Efficacy of UVADEX\u00ae (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS\u00ae CELLEX\u00ae Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-09-11"

Study condition terms

  • Steroid Refractory Acute Graft Versus Host Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.